Histone Deacetylase: Potential Drug Targets and Biomarkers (P6479)

Target Name: Histone deacetylase

NCBI ID: P6479

Histone deacetylase

Other Name(s): HDAC | Histone deacetylase

Histone Deacetylase: Potential Drug Targets and Biomarkers

Histone deacetylase (HDAC) is a protein that plays a critical role in the regulation of gene expression and DNA replication. It is a highly conserved protein that can be found in all eukaryotic cells, and it is involved in the covalent cross-linking of histones, which are the protein subunits of the nucleosome. HDACs are also known as Nonspecific Deacetylases (NSDs) and are categorized into two subtypes, HDAC-1 and HDAC-2.

HDACs are involved in the histone-DNA complex, which is the primary scaffold of the nucleus. The histone-DNA complex plays a vital role in regulating gene expression and DNA replication. The histone-DNA complex consists of histones, DNA, and a variety of non-histone proteins, including HDACs. HDACs are responsible for the covalent cross-linking of histones, which provides stability to the nucleosome.

HDACs are also involved in the regulation of DNA replication. During DNA replication, HDACs help to ensure that the replicated DNA is correctly authenticated and that the double helix is maintained. They also play a role in the regulation of DNA damage repair.

HDACs have been identified as potential drug targets due to their involvement in the regulation of gene expression and DNA replication. They are also a potential biomarker for a variety of diseases, including cancer.

One of the main advantages of HDACs as drug targets is their specificity. HDACs are only expressed in certain tissues and cells, which makes them more targeted than many other proteins. This also makes them less likely to have off-target effects, which can be a concern when targeting a protein.

Another advantage of HDACs as drug targets is their ability to modulate gene expression. HDACs can be used to inhibit gene expression by binding to specific mRNAs and preventing their translation into proteins. This can be a useful tool for treating diseases where over-expression of certain genes is causing problems.

HDACs are also involved in the regulation of cellular processes that are important for human health, such as cell growth, apoptosis, and inflammation. They are also involved in the regulation of DNA replication, which is critical for the maintenance of the genetic integrity of the cell.

In addition to their potential as drug targets and biomarkers, HDACs are also of interest in the context of cancer. Many studies have suggested that HDACs may be involved in the regulation of cancer cell growth and survival. For example, HDACs have been shown to be involved in the regulation of the cell cycle, which is a critical process for cancer cell growth. They have also been shown to play a role in the regulation of apoptosis, which is a critical process for cancer cell death.

In conclusion, HDACs are a promising drug target and biomarker due to their specificity, ability to modulate gene expression, and involvement in the regulation of cellular processes that are important for human health. They may be useful for the treatment of a variety of diseases, including cancer. Further research is needed to fully understand the role of HDACs in the regulation of gene expression and DNA replication.

Protein Name: Histone Deacetylase (nonspecified Subtype)

The "Histone deacetylase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Histone deacetylase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets